dopamine 3-o-sulfate has been researched along with kynurenine in 1 studies
Studies (dopamine 3-o-sulfate) | Trials (dopamine 3-o-sulfate) | Recent Studies (post-2010) (dopamine 3-o-sulfate) | Studies (kynurenine) | Trials (kynurenine) | Recent Studies (post-2010) (kynurenine) |
---|---|---|---|---|---|
45 | 2 | 2 | 4,137 | 115 | 2,031 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bruckner, T; Deisenhammer, EA; Egeter, J; Galffy, M; Giesinger, JM; Gostner, JM; Holzner, B; Hüfner, K; Lehmann, J; Nelles, P; Oberhammer, M; Rockenschaub, J; Sacher, M; Sperner-Unterweger, B; Tymoszuk, P; Vedova, S | 1 |
1 other study(ies) available for dopamine 3-o-sulfate and kynurenine
Article | Year |
---|---|
The effect of inflammation, SARS-CoV-2 infection, age and mental health on serotonin, and kynurenine and catecholamine pathway metabolites.
Topics: COVID-19; Cross-Sectional Studies; Dopamine; Humans; Inflammation; Kynurenine; Mental Health; Phenylalanine; SARS-CoV-2; Serotonin; Tryptophan; Tyrosine | 2023 |